OACCU — Stock Film
STOCK FILMSCENE 1/10OACCU · $10.93
Stock Expert AI presents
OACCU
Oaktree Acquisition Corp. III Life Sciences Unit
~4 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Oaktree Acquisition Corp. III Life Sciences Unit. What it actually does.

OACCU is a special purpose acquisition company (SPAC). It was created to merge with or acquire another company. Now — the numbers.

on the stock market since 2024
3 employees
$262.4M market value
Revenue last year:
$0
The net profit left over:
$7.3M
The company reported no sales at all last year — the profit came from somewhere other than selling.

There is not enough trading history here to call this an established business.

Cash on hand:
$1.4M
Total debt:
$12K
The cash outweighs the debt.

If every debt were paid off today, $1.4M would still be left — though next to the size of the company that is a thin cushion.

THE PRICE TAG
MARKET VALUE / ANNUAL PROFIT
36×

The market pays 36× for every dollar this company earns in a year — a price that already assumes things go well.

Against companies in its own sector, it looks cheaper than 33% of them.

No analyst target is on record for this company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
36
weak

Clearly below the class average.

FINANCIAL STRENGTH
11
very weak

Clearly below the class average.

VALUATION
33
very weak

Clearly below the class average.

GROWTH
45
weak

Clearly below the class average.

PRICE MOMENTUM
58
average

The price is looking for direction — no strong breakout, no collapse.

WORTH WATCHING

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

THE FIVE-YEAR JOURNEY
Bumpy, but the direction is up.

The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.

THE BRIGHT SIDE

Our checks did not surface a specific strength to highlight here.

1
THE RISKS · 1/3
A thin financial cushion

The balance sheet offers little cushion against a rough stretch. Report-card grade: 11/100.

2
THE RISKS · 2/3
The price runs ahead of the earnings

Today’s price already includes part of tomorrow’s optimism. Report-card grade: 33/100.

3
THE RISKS · 3/3
The business trails its class

Measured against its sector, the quality of the business sits below the class average. Report-card grade: 36/100.

FINALE · THE GRADE
—
grade pending

We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.

One-line summary: few numbers, an untested story. Keep watching.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: the growth trend, earnings execution, the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Oct 4, 2026 · stockexpertai.com · Stock Film